DrugRisk Update: Bayer Pays Approx. $1 Billion So Far In Yaz Settlements

Share Article

The Drug Resource Center is the premiere source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com.

yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The birth control safety advocates at DrugRisk.com are alerting those who have taken the oral contraceptives Yaz or Yasmin of new information added to the site which shows Bayer continues to compensate victims of blood clot-type injuries related to the drugs.

“The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. Many visitors to the site are concerned over blood clot side effects and want to know if Bayer is still compensating victims,” explains DrugRisk representative Ryan Mayer.

The resource center contains studies from the British Medical Journal and FDA which warned birth control pills containing the hormone drospirenone, like Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.*

Now, DrugRisk has obtained the latest financial information from Bayer, which shows the company faces as many as 13,600 total claims relating to Yaz side effects.** So far, they have spent approximately $1 billion to settle around 4,800 claims involving blood clot injuries like deep vein thrombosis (DVT) or Yaz pulmonary embolism.**

The records also indicate Bayer will continue to evaluate blood clot claims for settlement on a case-by-case basis.** This is positive news for patients who have suffered blood clot injuries but have yet to file a case.

In the United States, Yaz lawsuits have been consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

Due to the specialized nature of the federal MDL court and litigation process, DrugRisk cautions that patients should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints"
**Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website